Revolution Medicines (RVMD) Enterprise Value (2018 - 2026)
Revolution Medicines' quarterly Enterprise Value came in at -$1.9 billion in Q1 2026, up 9.25% year-on-year from -$1.7 billion in Q1 2025, and up 5.81% quarter-over-quarter from -$2.0 billion in Q4 2025.
Revolution Medicines has reported Enterprise Value for 9 years, with the latest figure at -$1.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 9.25% year-over-year to -$1.9 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.9 billion (up 9.25% YoY), and the FY2025 full-year result was -$2.0 billion, up 11.52% from the prior year.
- Enterprise Value for Q1 2026 stood at -$1.9 billion, up from -$2.0 billion in the prior quarter.
- The five-year high for Enterprise Value was -$461.4 million in Q2 2022, with the low at -$2.3 billion in Q4 2024.
- Average Enterprise Value over 5 years is -$1.4 billion, with a median of -$1.6 billion recorded in 2024.
- Year-over-year, Enterprise Value advanced 28.61% in 2022 and sank 187.31% in 2023.
- Tracing RVMD's Enterprise Value over 5 years: stood at -$644.9 million in 2022, then slumped by 187.31% to -$1.9 billion in 2023, then declined by 23.55% to -$2.3 billion in 2024, then increased by 11.52% to -$2.0 billion in 2025, then climbed by 5.81% to -$1.9 billion in 2026.
- The last three Enterprise Value figures came in at -$1.9 billion (Q1 2026), -$2.0 billion (Q4 2025), and -$1.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.91 Bn |
| Dec 31, 2025 | -2.03 Bn |
| Sep 30, 2025 | -1.93 Bn |
| Jun 30, 2025 | -2.14 Bn |
| Mar 31, 2025 | -2.10 Bn |
| Dec 31, 2024 | -2.29 Bn |
| Sep 30, 2024 | -1.55 Bn |
| Jun 30, 2024 | -1.59 Bn |
| Mar 31, 2024 | -1.70 Bn |
| Dec 31, 2023 | -1.85 Bn |
| Sep 30, 2023 | -813.20 Mn |
| Jun 30, 2023 | -909.49 Mn |
| Mar 31, 2023 | -909.80 Mn |
| Dec 31, 2022 | -644.94 Mn |
| Sep 30, 2022 | -655.01 Mn |
| Jun 30, 2022 | -461.43 Mn |
| Mar 31, 2022 | -518.75 Mn |
| Dec 31, 2021 | -577.05 Mn |
| Sep 30, 2021 | -608.66 Mn |
| Jun 30, 2021 | -646.32 Mn |
| Mar 31, 2021 | -681.59 Mn |
| Dec 31, 2020 | -440.74 Mn |
| Sep 30, 2020 | -466.14 Mn |
| Jun 30, 2020 | -325.45 Mn |
| Mar 31, 2020 | -347.95 Mn |
| Dec 31, 2019 | -122.76 Mn |
| Sep 30, 2019 | -21.82 Mn |
| Jun 30, 2019 | -85.48 Mn |
| Mar 31, 2019 | -62.76 Mn |
| Dec 31, 2018 | -69.59 Mn |